Skip to content

References

  • (Ballerini V, 2025). Ballerini, V., Seri, E. A quantitative investigation of immigrants integration and detention in Europe. Qual Quant 59, 253–274 (2025). https://doi.org/10.1007/s11135-024-01926-6
  • (Bivegete S, 2023). Bivegete S, McNaughton AL, Trickey A, Thornton Z, Scanlan B, Lim AG, et al. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review. Euro Surveill. 2023 Jul;28(30):2200738. doi: 10.2807/1560-7917.ES.2023.28.30.2200738.
  • (Carpentier C, 2018). Carpentier C, Royuela L, Montanari L, Davis P. ‘The Global Epidemiology of Drug Use in Prison’, in Kinner SA, and Jody Rich JD (eds), Drug Use in Prisoners: Epidemiology, Implications, and Policy Responses (New York, 2018; online edn, Oxford Academic, 1 Mar. 2018). https://doi.org/10.1093/med/9780199374847.003.0002, accessed 24 Sept. 2024.
  • (Catie, 2019). CATIE, ‘Micro-elimination of hepatitis C: A pathway to achieve national elimination goals, 2019. Available at: https://www.catie.ca/prevention-in-focus/micro-elimination-of-hepatitis-c-a-pathway-to-achieve-national-elimination
  • (Cuadrado A, 2021). Cuadrado, A, Cobo C, Mateo M, Blasco AJ, Cabezas J, Llerena S, et al. Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting. International Journal of Drug Policy 88 (2021): 103031. doi: 10.1016/j.drugpo.2020.103031.
  • (Cuadrado A, 2018). Cuadrado A, Llerena S, Cobo C, Pallás JR, Mateo M, Cabezas J, et al. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. Am J Gastroenterol. 2018 Nov;113(11):1639-1648. doi: 10.1038/s41395-018-0157-x.
  • (ECDC, 2018). European Centre for Disease Prevention and Control. Systematic review on the prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC; 2018. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Prevention-control-BBV-prison-settings-systemativ-review.pdf
  • (ECDC, 2024). European Centre for Disease Prevention and Control. Prevention of hepatitis B and C in the EU/EEA. Stockholm: ECDC; 2024. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/evidence-brief-hepatitis-B-C-prevention-2024.pdf
  • (ECDC, 2024a). European Centre for Disease Prevention and Control. Monitoring of the responses to the hepatitis B and C epidemics in EU/EEA countries, 2023. Stockholm: ECDC; 2024. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Monitoring-responses-hepatitis-B-C-epidemics.pdf
  • (ECDC/EMCDDA, 2018). European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-on-BBV-in-prisons.pdf
  • (ECDC/EMCDDA, 2018a). European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on active case finding of communicable diseases in prison settings. Stockholm and Lisbon: ECDC and EMCDDA; 2018. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Active-case-finding-communicable-diseases-in-prisons.pdf
  • (ECDC/EMCDDA, 2023). European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction, Prevention and control of infectious diseases among people who inject drugs: 2023 update. Stockholm: ECDC; 2023. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-prevention-control-PWID-6-November.pdf
  • (EMCDDA, 2019). European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2019. Luxembourg: Trends and developments; 2019. Available at: https://www.euda.europa.eu/publications/edr/trends-developments/2019_en#:~:text=European%20Drug%20Report%202019%3A%20Trends%20and%20Developments%20The,problems%20as%20well%20as%20drug%20policy%20and%20responses
  • (EMCDDA, 2022). European Monitoring Centre for Drugs and Drug Addiction (2021), Prison and drugs in Europe: current and future challenges, Publications Office of the European Union, Luxembourg. Available at: https://www.euda.europa.eu/publications/insights/prison-and-drugs-in-europe_en
  • (EU, 2022). Commission Recommendation (EU) 2023/681 of 8 December 2022 on procedural rights of suspects and accused persons subject to pre-trial detention and on material detention conditions C/2022/8987. EUR-Lex - 32023H0681 - EN - EUR-Lex (europa.eu)
  • (EU, 2024). European Commission. Proposal for a council recommendation on vaccine preventable cancers, 2024. Available at: https://health.ec.europa.eu/document/download/a2ba1fde-a65f-4575-8187-e44c5a4c2573_en?filename=com_2024_45_1_act_en.pdf
  • (EUDA, 2024). EUDA, Statistical Bulletin 2024 – drug use and prison, 2024. Available at: https://www.euda.europa.eu/data/stats2024/dup_en
  • (EUDA, 2024). European Union Drugs Agency (EUDA), ‘Penalties for drug law offences in Europe at a glance’, 4 September 2024. Available at: https://www.euda.europa.eu/publications/topic-overviews/content/drug-law-penalties-at-a-glance_en
  • (European Court of Human Rights, 2017). European Court of Human Rights, Council of Europe. Factsheet – Prisoners’ health-related rights. Vienna: 2017.
  • (Eurostat, 2021). Eurostat, ‘EU prisons in 2021: populations and overcrowding’, 12 May 2023. Available at: https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230512-2
  • (Hajarizadeh B, 2021). Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, et al.; SToP-C study group. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7.
  • (Jones AM, 2022). Jones AM, Royal N, Ludlow-Rhodes A. Micro-eliminating hepatitis C in a network of 47 English Prisons through an industry, prison healthcare and patient organisation partnership. Journal of Hepatology 77 (2022): S554.
  • (Lazarus JV, 2018). Lazarus JV, Safreed-Harmon K, Thursz MR, Dillon JF, El-Sayed MH, Elsharkawy AM, et al. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations. Semin Liver Dis. 2018 Aug;38(3):181-192. doi: 10.1055/s-0038-1666841.
  • (Mongale E, 2024). Mongale, E, Allen S, Brew I, Ludlow-Rhodes A, Royal N, Waldron J, et al. Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population. JHEP Reports 6.1 (2024): 100937. doi: 10.1016/j.jhepr.2023.100937.
  • (Nakitanda AO, 2020). Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action. BMC Public Health. 2020 Nov 9;20(1):1670. doi: 10.1186/s12889-020-09515-6.
  • (Nakitanda AO, 2021). Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis. Epidemiol Infect. 2021 Jan 25;149:e59. doi: 10.1017/S0950268821000169.
  • (Nyblade L, 2019). Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019 Feb 15;17(1):25. doi: 10.1186/s12916-019-1256-2.
  • (Palmateer N, 2022). Palmateer N, Hamill V, Bergenstrom A, Bloomfield H, Gordon L, Stone J, et al. Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020). Int J Drug Policy. 2022 Nov;109:103872. doi: 10.1016/j.drugpo.2022.103872.
  • (PRI, 2023). Penal Reform International (PRI) and the Council of Europe. Guidance document on the European Prison Rules (2023). Available at: https://edoc.coe.int/en/european-prison-reform/11595-guidance-document-on-the-european-prison-rules.html
  • (Stöver H., 2016). Stöver H, Hariga F. Prison-based needle and syringe programmes (PNSP) – Still highly controversial after all these years. Drugs Educ Prev Policy. 2016;23(2):103–12.
  • (Salari N, 2022). Salari N, Darvishi N, Hemmati M, Shohaimi S, Ghyasi Y, Hossaini F, et al. Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis. Arch Virol. 2022 Apr;167(4):1025-1039. doi: 10.1007/s00705-022-05382-1.
  • (Smith JM, 2017). Smith JM, Uvin AZ, Macmadu A, Rich JD. Epidemiology and Treatment of Hepatitis B in Prisoners. Curr Hepatol Rep. 2017 Sep;16(3):178-183. doi: 10.1007/s11901-017-0364-8.
  • (Stasi C, 2019). Stasi C, Monnini M, Cellesi V, Salvadori M, Marri D, Ameglio M, Gabbuti A, Di Fiandra T, Voller F, Silvestri C. Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study. Vaccine. 2019 Mar 7;37(11):1412-1417. doi: 10.1016/j.vaccine.2019.01.049.
  • (Stone J, 2017). Stone J, Martin NK, Hickman M, Hutchinson SJ, Aspinall E, Taylor A, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction. 2017 Jul;112(7):1302-1314. doi: 10.1111/add.13783.
  • (Tarján A, 2019). Tarján A, Horváth G, Stöver H. European Mapping of harm reduction interventions in prisons. Frankfurt, 2019. Available at https://www.aidsactioneurope.org/sites/default/files/mapping_report_final.pdf
  • (Tran NT, 2018). Tran NT, Baggio S, Dawson A, O’Moore É, Williams B, Bedell P, et al. Words matter: a call for humanizing and respectful language to describe people who experience incarceration. BMC Int Health Hum Rights. 2018 Nov 16;18(1):41. doi: 10.1186/s12914-018-0180-4.
  • (United Nations, 2015). United Nations. Transforming our world: the 2030 agenda for sustainable development. New York: UN; 2015.
  • (United Nations, 2015b). United Nations, Resolution adopted by the General Assembly on 17 December 2015, 70/175. United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules). 2015. Available at https://documents.un.org/doc/undoc/gen/n15/443/41/pdf/n1544341.pdf
  • (United Nations, 2002). United Nations, Resolution adopted by the General Assembly on 18 December 2022, A/RES/57/199. Optional Protocol to the Convention against Torture and other Cruel, Inhuman or Degrading Treatment or Punishment. 2002. Available at https://www.ohchr.org/sites/default/files/cat-one.pdf
  • (UNODC, 2021). United Nations Office on Drugs and Crime (UNODC), Data Matters, 2021. Available at: https://www.unodc.org/documents/data-and-analysis/statistics/DataMatters1_prison.pdf
  • (Vicente-Alcalde N, 2020). Vicente-Alcalde, N.; Ruescas-Escolano, E.; Harboe, Z.B.; Tuells, J. Vaccination Coverage among Prisoners: A Systematic Review. Int. J. Environ. Res. Public Health 2020, 17, 7589. https://doi.org/10.3390/ijerph17207589
  • (Vroling H, 2018). Vroling H, Oordt-Speets AM, Madeddu G, Babudieri S, Monarca R, O’Moore E, et al. A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA. J Viral Hepat. 2018; 25: 1406–1422. https://doi.org/10.1111/jvh.12998
  • (WHO, 2016). World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Geneva: WHO; 2016. Available at https://www.who.int/publications/i/item/WHO-HIV-2016.06
  • (WHO, 2023). Guidance for country validation of viral hepatitis elimination and path to elimination: technical report. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. Available at: https://www.who.int/publications/i/item/9789240078635
  • (WHO, 2024). Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024. Available at: https://www.who.int/publications/i/item/9789240091672
  • (Wiessing L, 2021). Wiessing, L, Kalamara E, Stone J, Altan P, Van Baelen L, Fotiou A, et al. Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable? Euro Surveill. 2021 Dec;26(49):2002093. doi: 10.2807/1560-7917.ES.2021.26.49.2002093.
  • (Winter RJ, 2022). Winter, RJ, Holmes JA, Papaluca TJ, Thompson AJ. The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience. Viruses 2022, 14, 497. https://doi.org/10.3390/v14030497.